Utilizing an experimental design and scale up of a wet fluidized bed agglomeration process, to produce novel carbon agglomerates and tablets
DOI:
https://doi.org/10.61841/cxc8f761Keywords:
Scale up, Wet agglomeration, Fluidized bed, Design of Experiments, Carbon agglomerates and tabletsAbstract
Wet granulation and agglomeration processes are widely used in the pharmaceutical industry. This study was performed, aimed at developing a systematic approach to scale up a carbon agglomeration process from 10 kg to 100 kg. The goal was to achieve similar granule sizes with different granulators during production. The formulation of the powder bed at the start of the agglomeration process was based on carboxymethyl cellulose as a binder, carbon and peroxide powder. In the first production step this composition was used to produce agglomerates. Agglomerates were evaluated for particle flow and particle size. Finally, compressive strength of cylindrical carbon tablets was measured, following compression with a five cavity mechanical press. It was found that the agglomeration liquid quantity, the inlet air flowrate and the droplet size distribution play a fundamental role in the upscaling process. Therefore, these mentioned parameters had to be systematically scaled up for different batch sizes in order to achieve similar particle growth in the different fluidized bed sizes. A previous study, through a design of experiments has shown that a target geometric mean granule size of around 575 µm is desirable in terms of the granules flowability and granules properties. For example: The compressive strength of the carbon tablets. Furthermore, a DoE for the spraying parameters was applied to compare the final tablet properties. The scale up process from a laboratory to a production size granulator, was successfully performed. This was based on the granule’s properties and the mechanical stability of the carbon tablets.
References
[1] Matsen, J. M., Scale-up of fluidized bed processes: Principle and practice, Powder Technology, Vol. 88, Issue 3, Pages 237-244, 1996
[2] Faure, A., York, P., Rowe, R.C., Process control and scale-up of pharmaceutical wet granulation processes: a review, Review article, European Journal of Pharmaceutics and Biopharmaceutics 52, 2001, Pages 269–277
[3] Godek, E.J., Bring Fluid Bed Granulation Up to Scale, Scaling up commercial manufacturing with the same quality and results, Pharmaceutical Manufacturing magazine, 2013
[4] Mehta, A.M., Scale-up considerations in the fluid-bed process for controlled-release products, 1988, Pharm. Tech. 12, 46–52
[5] Schaefer, T., Worts, O., Control of fluidized bed granulation, IV Effects of binder solution and atomization on granule size and size distribution, Arch. Pharm. Chemi. Sci.
Ed. 6, 1978, Pages 14–25
[6] Watano, S., Fukushima, T., Miyanami, K., Heat transfer and granule growth rate in fluidized bed granulation, 1996, Chem. Pharm. Bull. 44, 572–576
[7] Waldie, B., Growth mechanism and the dependence of granule size on drop size in fluidized-bed granulation, 1991, Chemical Engineering Science, Vol. 46, No. II, pp. 2X- 2785
[8] Schick, R.J., Spray Technology Guide: Understanding Drop Size, Spray Analysis and Research Services, Wheaton, IL 2008
[9] Hartung, A., Johansson, E., Knoell, M., Valthorsson, H., Langguth, P., "Design Space" Determination of a Paracetamol Fluid Bed Granulation Using Design of Experiments,
Cantor Verlag, Aulendorf (Germany), 2012, Pharm. Ind. 74, Nr. 4,644-650
[10] Diez, E., Meyer, K., Bück, A., Tsotsas, E., Heinrich, S., Influence of process conditions on the product properties in a continuous fluidized bed spray granulation process, Chemical Engineering Research and Design, Volume 139, November 2018, Pages 104- 115
[11] Terrazas-Velarde, K., Peglow, M., Tsotsas, E., Kinetics of fluidized bed spray agglomeration for compact and porous particles, Chemical Engineering Science,
Volume 66, Issue 9, 1 May 2011, Pages 1866-1878
[12] Rambali, B. et al., Using experimental design to optimize the process parameters in fluidized bed granulation, Drug Dev Ind Pharm, 2001, 27:47-55
[13] Schmidt-Lehr, S., Moritz, H-U., Jürgens, K.C., Online Control of Particle Size during Fluidised Bed Granulation, Pharm. Ind. 69, Nr. 4, 478?484, 2007
[14] Dietrich, S., Petrak, D., In-Line Particle Size Characterization of Multiparticulate Systems, Springer-Verlag, Chapter 12, Pages 301-332, 2017
[15] DIN ISO 697: 1984-01, Determination of apparent density; Method by measuring the mass of a given volume, 1984
[16] DIN 53211 :1987-06, Determination of flow time by DIN cup, 1987
[17] Minitab 17 Statistical Software, Minitab StatGuide, Analyze Factorial Design, 2014
[18] DIN ISO 2859-1:2014-08, Sampling procedure for inspection by attributes, Part 1 : Sampling schemes indexed by acceptance quality limit (AQL) for lot-by-lot inspection (ISO 2859-1:1999 + COR. 1:2001 + AMD. 1:2011), 2004
[19] Godek, E. J., Bring Fluid Bed Agglomeration Up to Scale, Scaling up commercial manufacturing with the same quality and results, Pharmaceutical Manufacturing magazine, 2013
[20] Gerstner, S., Wirbelschicht, Schlick Atomizing Technologies, Internal Presentation, 2017
[21] Oelofse, M., Rack, R., Hilden, M., Langguth, P., Optimization of product characteristics of porous carbon agglomerates using a design of experiments in a fluidized bed agglomeration, Pariticulogy, Pages 258-269, 2024
[22] Godek, E. J., Bring Fluid Bed Agglomeration Up to Scale, Scaling up commercial manufacturing with the same quality and results, Pharmaceutical Manufacturing magazine, 2013
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
